Clinical Trials Browser

Phase 2 × Prolactinoma × Temozolomide × Clear all

NCT00601289 2020-07-31

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma